| 1 |
-
Impact of non-alcoholic hepatic steatosis on prognosis and clinical outcomes in gastric cancer patients undergoing laparoscopic distal gastrectomy
-
9/24/2025 9:01:56 AM | Browse: 59 | Download: 44
|
| 2 |
-
Comparative evaluation of three traditional herbal formulas on gastrointestinal motility in a mouse model of cold stress-induced dyspepsia
-
9/18/2025 9:55:58 AM | Browse: 372 | Download: 78
|
| 3 |
-
Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression
-
8/27/2025 9:21:11 AM | Browse: 141 | Download: 157
|
| 4 |
-
Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment
-
8/27/2025 3:43:59 AM | Browse: 75 | Download: 113
|
| 5 |
-
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives
-
7/25/2025 12:09:44 PM | Browse: 42 | Download: 136
|
| 6 |
-
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
-
6/26/2025 7:27:54 AM | Browse: 57 | Download: 280
|
| 7 |
-
Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease?
-
5/26/2025 9:15:10 AM | Browse: 55 | Download: 275
|
| 8 |
-
Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy: A retrospective cohort study
-
4/2/2025 10:54:11 AM | Browse: 96 | Download: 472
|
| 9 |
-
Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities
-
2/24/2025 5:39:17 AM | Browse: 83 | Download: 380
|
| 10 |
-
ILF3 inhibits p-AMPK expression to drive non-alcoholic fatty liver disease progression
-
2/20/2025 8:40:00 AM | Browse: 107 | Download: 469
|
| 11 |
-
Liver function linked to bone health: A bibliometric of the liver-bone axis
-
2/20/2025 8:39:56 AM | Browse: 104 | Download: 403
|
| 12 |
-
Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection
-
11/29/2024 2:50:17 PM | Browse: 150 | Download: 512
|
| 13 |
-
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease
-
11/26/2024 7:20:28 AM | Browse: 104 | Download: 391
|
| 14 |
-
Vitamin D 1,25-Dihydroxyvitamin D₃ reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization
-
11/12/2024 12:23:35 PM | Browse: 139 | Download: 575
|
| 15 |
-
Addressing the alarming link between nonalcoholic fatty liver disease and cardiovascular mortality in men
-
9/19/2024 12:00:22 PM | Browse: 170 | Download: 445
|
| 16 |
-
Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review
-
8/21/2024 11:22:32 PM | Browse: 136 | Download: 558
|
| 17 |
-
Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction–associated steatotic liver disease
-
8/9/2024 12:51:13 PM | Browse: 159 | Download: 502
|
| 18 |
-
Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!
-
7/24/2024 1:09:01 PM | Browse: 166 | Download: 496
|
| 19 |
-
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need
-
7/1/2024 7:39:37 AM | Browse: 142 | Download: 416
|
| 20 |
-
From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology
-
6/20/2024 3:42:22 AM | Browse: 234 | Download: 436
|
| 21 |
-
In-hospital outcomes in COVID-19 patients with non-alcoholic fatty liver disease by severity of obesity: Insights from national inpatient sample 2020
-
6/20/2024 3:42:22 AM | Browse: 174 | Download: 643
|
| 22 |
-
Non-alcoholic fatty liver disease in type 2 diabetes: Emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies
-
6/14/2024 9:10:00 AM | Browse: 157 | Download: 466
|
| 23 |
-
Management of non-alcoholic fatty liver disease: Lifestyle changes
-
6/6/2024 5:43:14 AM | Browse: 226 | Download: 675
|
| 24 |
-
Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease
-
5/22/2024 11:33:24 AM | Browse: 159 | Download: 544
|
| 25 |
-
Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
-
5/22/2024 11:33:24 AM | Browse: 156 | Download: 580
|
| 26 |
-
Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment
-
5/5/2024 10:12:21 AM | Browse: 171 | Download: 530
|
| 27 |
-
Genetically predicted fatty liver disease and risk of psychiatric disorders: A mendelian randomization study
-
5/5/2024 10:11:21 AM | Browse: 196 | Download: 640
|
| 28 |
-
Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease
-
4/19/2024 3:18:01 AM | Browse: 192 | Download: 625
|
| 29 |
-
Non-alcoholic fatty liver disease and sleep disorders
-
3/27/2024 1:28:19 PM | Browse: 205 | Download: 710
|
| 30 |
-
Sex and racial disparities in non-alcoholic fatty liver disease-related cardiovascular events: National inpatient sample analysis (2019)
-
3/21/2024 9:42:02 AM | Browse: 244 | Download: 731
|
| 31 |
-
Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
-
2/26/2024 1:28:46 PM | Browse: 248 | Download: 887
|
| 32 |
-
Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges
-
1/26/2024 7:56:29 AM | Browse: 313 | Download: 849
|
| 33 |
-
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
-
12/25/2023 6:03:15 AM | Browse: 267 | Download: 741
|
| 34 |
-
Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
-
9/25/2023 9:07:43 AM | Browse: 322 | Download: 1101
|
| 35 |
-
Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
-
8/22/2023 7:39:26 AM | Browse: 326 | Download: 999
|
| 36 |
-
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
-
7/25/2023 11:07:10 AM | Browse: 326 | Download: 879
|
| 37 |
-
Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients
-
6/25/2023 2:17:08 PM | Browse: 335 | Download: 1059
|
| 38 |
-
Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
-
6/16/2023 9:52:18 AM | Browse: 335 | Download: 1266
|
| 39 |
-
Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients
-
6/7/2023 6:39:13 AM | Browse: 372 | Download: 1452
|
| 40 |
-
Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?
-
5/24/2023 9:31:05 AM | Browse: 340 | Download: 915
|
| 41 |
-
Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications
-
5/7/2023 7:47:34 AM | Browse: 341 | Download: 923
|
| 42 |
-
Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: A new challenge on the horizon in the United States
-
4/20/2023 7:26:29 AM | Browse: 341 | Download: 1036
|
| 43 |
-
Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: High liver cancer, low comorbidity in hepatitis B virus
-
4/13/2023 8:14:59 AM | Browse: 362 | Download: 1379
|
| 44 |
-
Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
-
4/7/2023 5:51:03 AM | Browse: 324 | Download: 1028
|
| 45 |
-
To scan or not to scan: Use of transient elastography in an integrated health system
-
3/22/2023 11:20:34 AM | Browse: 406 | Download: 1246
|
| 46 |
-
Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study
-
2/24/2023 1:35:50 PM | Browse: 400 | Download: 1195
|
| 47 |
-
Progressive changes in platelet counts and Fib-4 scores precede the diagnosis of advanced fibrosis in NASH patients
-
2/24/2023 1:35:50 PM | Browse: 392 | Download: 1188
|
| 48 |
-
Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
-
2/24/2023 1:35:50 PM | Browse: 400 | Download: 971
|
| 49 |
-
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
-
1/20/2023 1:48:21 PM | Browse: 390 | Download: 855
|
| 50 |
-
Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis
-
1/16/2023 6:02:17 AM | Browse: 377 | Download: 1170
|
